Detection of minimal residual disease.
Deptala
A
A
Brander Cancer Research Institute, New York Medical College, Hawthorne, New York 10532, USA.
Mayer
S P
SP
D014408:Biomarkers, Tumor / Q000032:analysis*; D001856:Bone Marrow Examination; D003582:Cytogenetics / Q000379:methods; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D016130:Immunophenotyping / Q000379:methods*; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D007621:Karyotyping; D007938:Leukemia / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D008198:Lymph Nodes / Q000378:metabolism / Q000601:surgery; D008223:Lymphoma / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D009101:Multiple Myeloma / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology; D018365:Neoplasm, Residual / Q000175:diagnosis*; D016133:Polymerase Chain Reaction / Q000379:methods; D012074:Remission Induction
D014408:Biomarkers, Tumor